About 100,000 of the estimated million people in the United States with multiple sclerosis (MS) have a progressive form of ...

The Valhalla Foundation awarded Octave Bioscience funding to further develop a biomarker blood test for assessing disease ...

Most relapsing MS patients on Mavenclad did not have confirmed disability progression for at least four years, new Phase 4 ...

Scientists have identified an unusual type of brain cell that may play a vital role in progressive multiple sclerosis (MS), ...

Scientists have identified an unusual type of brain cell that may play a vital role in progressive multiple sclerosis (MS), ...

Octave Bioscience, Inc., a commercial-stage precision care company pioneering biomarker-driven solutions for multiple ...

Researchers have identified a rare type of brain cell that may drive the chronic inflammation and neurodegeneration seen in progressive multiple sclerosis (MS).

BUFFALO, N.Y. – In recent years, researchers studying multiple sclerosis have concluded that white matter lesion volume in the brain, long considered the best way to monitor MS disease progression, ...

Although menopause is not the primary driver of multiple sclerosis disease progression, there is still some symptom overlap, such as brain fog, urinary dysfunction and vasomotor symptoms, according to ...

Multiple sclerosis (MS) is an autoimmune condition in which the protective insulation surrounding ... | Cell And Molecular Biology ...